Nurix Therapeutics, Inc. (NASDAQ:NRIX) Earnings Report Overview

Nurix Therapeutics, Inc. (NASDAQ:NRIX) reported an earnings per share (EPS) of -$1.03, missing the estimated EPS of -$0.91, marking a significant increase from the $0.67 loss per share in the same quarter last year.The company's revenue for the quarter was $7.89 million, falling short of the estimated $13.27 million, representing a 57.71% miss from the Zacks Consensus Estimate.Despite financial challenges, NRIX maintains a strong current ratio of 5.35 and a low debt-to-equity ratio of 0.15, indicating good ...